Self-assembling protein nanoparticles in the design of vaccines
about
Advanced Nanobiomaterials: Vaccines, Diagnosis and Treatment of Infectious DiseasesReverse vaccinology 2.0: Human immunology instructs vaccine antigen designThe S. aureus 4-oxalocrotonate tautomerase SAR1376 enhances immune responses when fused to several antigens.Classification of self-assembling protein nanoparticle architectures for applications in vaccine designDevelopment of a Novel Virus-Like Particle Vaccine Platform That Mimics the Immature Form of Alphavirus.Functional inclusion bodies produced in the yeast Pichia pastoris.Construction and immunological characterization of CD40L or GM-CSF incorporated Hantaan virus like particle.Latest options for treatment of bronchiolitis in infants.Respiratory syncytial virus vaccines: an update on those in the immediate pipeline.Adjuvant formulations for virus-like particle (VLP) based vaccines.Nanoparticle orientationally displayed antigen epitopes improve neutralizing antibody level in a model of porcine circovirus type 2.Characterization of the disassembly and reassembly of the HBV glycoprotein surface antigen, a pliable nanoparticle vaccine platform.Design of coiled-coil protein-origami cages that self-assemble in vitro and in vivo.A Multivalent Structure-Specific RNA Binder with Extremely Stable Target Binding but Reduced Interaction with Nonspecific RNAs.Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1.Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles.TLR-adjuvanted nanoparticle vaccines differentially influence the quality and longevity of responses to malaria antigen Pfs25.
P2860
Q26744748-2993F3C6-7112-4ACC-8322-9F2765BEF0AFQ28075274-D6523483-B957-4B66-BA85-A8C40AE42001Q29994694-A693F3C6-2BCC-4899-A726-91F6A0B8BCE6Q33630220-CCD24684-AB64-47BD-A8D3-C4351BCBB6AAQ33876183-833B1951-4D15-44F4-932E-DE694643484EQ37302292-03B175E3-B53F-4890-B123-08BCFC1C8B39Q37665363-A2003CB2-F77D-462E-8133-4CAC6AEA0C95Q38744226-8719B452-DEEE-4E92-971D-C2AB7D505A07Q38803541-31166267-5286-44A8-9AE3-7AF6085E40CDQ40093469-ACAD5E9E-E5A1-41F7-BD84-FD9B32E254A0Q40109161-5CFCF741-2150-4C39-BAD4-AF74A836BAF1Q40382460-85D54181-E75A-4AB7-AB69-59285CF4EE57Q47441562-04CD5F01-2C53-455C-9A0C-2891C0272D5AQ47601857-7F7DDEC2-F620-4952-B8FC-52DAA2CC17AFQ52655238-9572A63E-576D-4985-A21A-D8DAE4703721Q55344910-B086841E-37BD-4B50-9E26-24878911EF8AQ55379719-DF8A98DA-D79B-4281-9B66-467DBAB80743
P2860
Self-assembling protein nanoparticles in the design of vaccines
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Self-assembling protein nanoparticles in the design of vaccines
@ast
Self-assembling protein nanoparticles in the design of vaccines
@en
Self-assembling protein nanoparticles in the design of vaccines
@nl
type
label
Self-assembling protein nanoparticles in the design of vaccines
@ast
Self-assembling protein nanoparticles in the design of vaccines
@en
Self-assembling protein nanoparticles in the design of vaccines
@nl
prefLabel
Self-assembling protein nanoparticles in the design of vaccines
@ast
Self-assembling protein nanoparticles in the design of vaccines
@en
Self-assembling protein nanoparticles in the design of vaccines
@nl
P2093
P2860
P921
P3181
P1476
Self-assembling protein nanoparticles in the design of vaccines
@en
P2093
Enrico Malito
Jacinto López-Sagaseta
Matthew J Bottomley
P2860
P3181
P356
10.1016/J.CSBJ.2015.11.001
P407
P577
2016-01-01T00:00:00Z